Sign In
Buy PDCO
$31.33
+0 (+0%)
At Close: Jul 16, 2025
Thermo Fisher (TMO) to Offer Wheat & Sesame Allergy Testing
04:38pm, Monday, 22'nd Aug 2022 Zacks Investment Research
Thermo Fisher's (TMO) ImmunoCAP blood tests receive FDA approval for wheat and sesame allergy diagnosis.
PDCO vs. CNMD: Which Stock Is the Better Value Option?
03:40pm, Monday, 22'nd Aug 2022 Zacks Investment Research
PDCO vs. CNMD: Which Stock Is the Better Value Option?
Here's Why You Should Buy ShockWave Medical (SWAV) Stock
02:02pm, Monday, 22'nd Aug 2022 Zacks Investment Research
ShockWave Medical (SWAV) continues to benefit from solid R&D efforts and commitment to clinical studies.
Here's Why You Should Hold on to NextGen (NXGN) Stock Now
01:58pm, Monday, 22'nd Aug 2022 Zacks Investment Research
NextGen's (NXGN) solid product portfolio and continued demand for its solutions raise optimism about the stock.
PDCO vs. CNMD: Which Stock Is the Better Value Option?
12:48pm, Monday, 22'nd Aug 2022
PDCO vs. CNMD: Which Stock Is the Better Value Option?
QIAGEN's (QGEN) New Syndromic Test to Combat Monkeypox Spread
06:30pm, Friday, 19'th Aug 2022 Zacks Investment Research
QIAGEN (QGEN) joins the global fight against monkeypox with the launch of its novel QIAstat-Dx Viral Vesicular Panel RUO.
Here's Why You Should Hold on to Catalent (CTLT) Stock Now
02:16pm, Friday, 19'th Aug 2022 Zacks Investment Research
Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism about the stock.
Teleflex (TFX) Hit by Urolift Volume Decline, Cost Pressure
01:48pm, Friday, 19'th Aug 2022 Zacks Investment Research
In the Americas, growth within the Surgical business of Teleflex (TFX) is offset by a decline in Interventional Urology.
Haemonetics (HAE) Hits 52-Week High: What's Aiding the Stock?
01:38pm, Friday, 19'th Aug 2022 Zacks Investment Research
Investors are optimistic about Haemonetics' (HAE) potential in its Plasma franchise.
Here's Why You Should Retain PerkinElmer (PKI) Stock Now
12:57pm, Friday, 19'th Aug 2022 Zacks Investment Research
PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.
Edwards Lifesciences (EW) Gets CE Mark for PASCAL Precision
04:44pm, Thursday, 18'th Aug 2022 Zacks Investment Research
Edwards Lifesciences' (EW) PASCAL Precision system enables precise navigation and implant delivery during mitral and tricuspid regurgitation treatment.
Here's Why Investors Should Retain Hologic (HOLX) Stock for Now
04:42pm, Thursday, 18'th Aug 2022 Zacks Investment Research
Investors are optimistic about Hologic's (HOLX) better-than-expected results and expanded Panther installed base.
Here's Why You Should Retain Cooper Companies (COO) Stock Now
02:30pm, Thursday, 18'th Aug 2022 Zacks Investment Research
Cooper Companies (COO) continues to benefit from strength in its business segments. Its acquisitions are likely to boost the top line further.
IDEXX (IDXX) Suffers From Macro Headwinds, Cost Constraints
02:10pm, Thursday, 18'th Aug 2022 Zacks Investment Research
The strengthening of the rate of exchange for the U.S. dollar relative to other currencies has a negative impact on IDEXX's (IDXX) revenues.
3 Reasons to Hold QuidelOrtho (QDEL) Stock in Your Portfolio
01:54pm, Thursday, 18'th Aug 2022 Zacks Investment Research
Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.
